Blueclinical is a translational medicine company devoted to the development of medicines and medical devices.

Through our three business units we offer a variety of innovative services to institutions, startups and established companies, with the aim of bringing their projects to clinical practice.

News

Oct 2016
Blueclinical is a NOS Innovation Award finalist
Blueclinical is organized into three distinct but highly complementary business units: R & D Blueclinical, Blueclinical Phase I and Blueclinical CRP. Blueclinical’s organization provides an integrated approach in translational research and constitutes a unique and highly innovative concept in Portugal and internationally. Thus, Blueclinical decided to apply for the NOS Innovation Awards and is currently on the list of finalists.

Sep 2016
EC granted € 5M to a consortium in which Blueclinical is responsible for the regulatory plan and early clinical trials
Blueclinical is part of a H2020 Consortium which is working on an innovative approach to treat Rheumatoid Arthritis. It should reach phase I clinical trials in 2018.

Sep 2016
Blueclinical has implemented and is managing the clinical trial of the first oncological drug.
Luzitin S.A. is one of the Portuguese start-ups which Blueclinical helped going from bench to clinical trials. Its Phase I/II clinical trial in advanced head and neck cancer is currently ongoing at Hospital CUF Porto and IPO Porto.

Sep 2016
Blueclinical has helped another portuguesa start-up company to reach clinical trials.
Personalized medicine is getting closer. The first Portuguese clinical trial based on a predictive genetic biomarker of body weight and/or fat mass reduction, is from a Portuguese start-up and has Blueclinical’s cooperation.

Sep 2016
Blueclinical CRP activity keeps growing
Blueclinical was created to serve the society, patients, institutions, clinical investigators and sponsors. Blueclinical CRP is a living proof of this.


If you would like to work at Blueclinical send us your CV to: recrutamento@blueclinical.pt